MRK vs RVTY: fair value comparison
Merck & Co., Inc. and Revvity, Inc. · Updated 2026-08-31
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, RVTY currently sits closer to the top of our discount ranking. RVTY carries the stronger quality grade. MRK carries the stronger momentum grade.
| MRK | RVTY | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $148.35 | $128.80 |
| 12-month range | $82.49–$130.20 | $86.68–$115.22 |
| Sector rank | #95 of 113 Healthcare | #91 of 113 Healthcare |
| Quality grade | C | A |
| Momentum grade | A | B |
| Leverage | Moderate | Low |
| Margin trend | Expanding | Contracting |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Overbought |
| DCF cross-check | Undervalued | Overvalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: MRK fair value analysis · RVTY fair value analysis